Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Perceived Cancer Risks May Not Reflect Actual Risks Or Prevention Needs
Working with a population of individuals at risk for gastrointestinal cancers, researchers at Fox Chase Cancer Center have learned that many people misjudge their actual degree of cancer risk and, therefore, their true need for prevention support. Strategies for accurately assessing cancer risk are critical for appropriately targeting educational, counseling, and diagnostic res to prevent cancer in as many individuals as possible, the investigators say.
generic viagra online
Savient Pharmaceuticals Receives Complete Response Letter From U.S. Food And Drug Administration For KRYSTEXXA(TM)
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) stating that the FDA can not at this time approve the Company"s Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
News of the day
Longevity Of Dental Fillings May Be Increased By Nanotechnology
Tooth-colored fillings may be more attractive than silver ones, but the bonds between the white filling and the tooth quickly age and degrade. A Medical College of Georgia researcher hopes a new nanotechnology technique will extend the fillings" longevity.
Endocrinology

Nonin Medical Announces FDA Clearance For Its Next-Generation Regional Oximetry System

Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, announced FDA clearance for its Model 7600 Regional Oximetry System. Introduced in June 2009 at the European Society of Anaesthesiology (ESA) conference in Milan, Italy, the innovative Model 7600 offers real-time monitoring of cerebral oxygenation for patients at risk of ischemia. Utilizing next-generation near-infrared spectroscopy (NIRS) -- Nonin"s proprietary EQUANOX(TM) regional oximetry (rSO2) technology -- the Model 7600 measures oxygen saturation in the cerebral cortex. The innovative sensor design effectively removes surface tissue effects that can influence measurement accuracy -- isolating measurements of the cerebral cortex and providing rSO2 values. The Model 7600 offers industry-leading signal processing to enhance efficiency and an intuitive user interface with Bluetooth(R) wireless connectivity to streamline file access and storage. With over 20 years of signal processing and NIRS sensor design expertise, Nonin"s innovative technologies enable clinicians to accurately monitor a patient"s true condition in the most challenging environments. About Nonin Medical Inc Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100 OEM partners worldwide. Nonin"s industry-leading capabilities in signal processing and sensor design, plus its on-going integration of features not available in competitive products, are the foundation of its leadership in innovation. Nonin Medical, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009